Kobayashi Pharmaceutical Co., Ltd. (TYO: 4967)

Kobayashi Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	52,064	71,536	96,233	95,024	78,253	75,580
Short-Term Investments	8,300	8,300	8,300	14,022	16,085	14,977
Cash & Short-Term Investments	60,364	79,836	104,533	109,046	94,338	90,557
Cash Growth	-39.32%	-23.63%	-4.14%	15.59%	4.18%	9.43%
Receivables	35,127	52,984	47,853	55,147	52,829	54,773
Inventory	30,829	22,081	17,678	15,107	14,139	15,086
Other Current Assets	6,029	3,430	2,828	2,589	2,919	2,296
Total Current Assets	132,349	158,331	172,892	181,889	164,225	162,712
Property, Plant & Equipment	65,790	47,665	34,778	22,524	20,821	21,180
Long-Term Investments	37,025	36,083	32,123	33,177	38,382	43,792
Goodwill	10,177	9,655	7,147	7,189	7,284	1,582
Other Intangible Assets	12,329	11,959	6,160	5,469	5,510	1,530
Long-Term Deferred Tax Assets	3,366	2,647	1,750	1,489	1,443	2,028
Other Long-Term Assets	2	1	2	1	1	2
Total Assets	262,254	267,473	255,827	252,554	238,366	233,398
Accounts Payable	15,064	17,305	18,056	17,444	15,926	17,112
Accrued Expenses	2,692	2,705	2,553	2,486	2,797	2,368
Short-Term Debt	-	-	-	1	13	19
Current Portion of Leases	423	379	261	169	170	190
Current Income Taxes Payable	19,342	29,884	25,317	25,662	26,756	30,000
Other Current Liabilities	8,409	5,838	5,622	4,941	4,445	3,744
Total Current Liabilities	45,930	56,111	51,809	50,703	50,107	53,433
Long-Term Leases	721	608	531	460	505	682
Long-Term Deferred Tax Liabilities	2,525	2,594	1,310	1,564	1,357	2,779
Other Long-Term Liabilities	2,378	2,405	2,244	2,209	1,855	1,784
Total Liabilities	52,521	62,657	57,928	56,955	55,784	60,741
Common Stock	3,450	3,450	3,450	3,450	3,450	3,450
Additional Paid-In Capital	522	522	522	4,183	4,183	4,183
Retained Earnings	202,806	205,681	194,285	200,534	187,071	173,650
Treasury Stock	-24,766	-24,766	-14,482	-23,706	-19,763	-19,762
Comprensive Income & Other	27,721	19,929	14,124	11,138	7,641	11,136
Total Common Equity	209,733	204,816	197,899	195,599	182,582	172,657
Shareholders' Equity	209,733	204,816	197,899	195,599	182,582	172,657
Total Liabilities & Equity	262,254	267,473	255,827	252,554	238,366	233,398
Total Debt	1,144	987	792	630	688	891
Net Cash (Debt)	59,220	78,849	103,741	108,416	93,650	89,666
Net Cash Growth	-39.94%	-23.99%	-4.31%	15.77%	4.44%	9.72%
Net Cash Per Share	790.00	1039.65	1344.98	1387.72	1198.14	1143.47
Filing Date Shares Outstanding	74.34	74.34	76.13	77.28	78.16	78.16
Total Common Shares Outstanding	74.34	74.34	76.01	77.74	78.16	78.16
Working Capital	86,419	102,220	121,083	131,186	114,118	109,279
Book Value Per Share	2821.31	2755.17	2603.46	2516.20	2335.91	2208.93
Tangible Book Value	187,227	183,202	184,592	182,941	169,788	169,545
Tangible Book Value Per Share	2518.56	2464.42	2428.40	2353.37	2172.23	2169.12

Source: S&P Capital IQ. Standard template. Financial Sources.